-
1Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
المؤلفون: Benjamin O. Lawson, Hung Thieu Khong, Junjie Ma, Joan Van Atta, Cheryl McGovern, Brian Khong, Abhijit Ray
المصدر: BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
BMC Cancerمصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Metastatic melanoma, Fever, Meperidine, Antineoplastic Agents, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, 030202 anesthesiology, Surgical oncology, Renal cell carcinoma, High dose interleukin-2, Internal medicine, Genetics, medicine, Humans, Renal Insufficiency, Adverse effect, Carcinoma, Renal Cell, Melanoma, Tramadol, Neoplasm Staging, Retrospective Studies, Dose-Response Relationship, Drug, Rigor prophylaxis, business.industry, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Kidney Neoplasms, Treatment Outcome, Oncology, Opioid, 030220 oncology & carcinogenesis, Stage iv melanoma, Interleukin-2, Female, Immunotherapy, business, medicine.drug, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa5d8ec79bc3e62627e21743f468623aTest
http://link.springer.com/article/10.1186/s12885-018-4810-yTest -
2
المؤلفون: Karl D. Lewis, Thomas Olencki, Thomas W. Flaig, Anthony Jarkowski, Dexiang Gao, Bruce G. Redman, Theodore F. Logan, Marcus Bolden, Elaine T. Lam, Neeraj Agarwal, Timothy M. Kuzel, Arun Sendilnathan, Paul Monk, Jamie Poust, Michael K.K. Wong
المصدر: Journal of Immunotherapy (Hagerstown, Md. : 1997)
مصطلحات موضوعية: Adult, Male, Sorafenib, renal cell carcinoma, Cancer Research, medicine.medical_specialty, tyrosine kinase inhibitor (TKI), sunitinib, Immunology, Antineoplastic Agents, Risk Factors, Renal cell carcinoma, Internal medicine, Clinical Studies, medicine, Carcinoma, Humans, Immunology and Allergy, high-dose interleukin-2, Neoplasm Metastasis, Adverse effect, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Retrospective Studies, Pharmacology, medicine.diagnostic_test, business.industry, Sunitinib, Cardiac stress test, Retrospective cohort study, Middle Aged, Prognosis, medicine.disease, Kidney Neoplasms, 3. Good health, Surgery, Treatment Outcome, Cardiovascular Diseases, Heart failure, Interleukin-2, Female, sorafenib, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0a500825e445ce76e21c087d2895c9Test
https://doi.org/10.1097/cji.0000000000000044Test -
3
المؤلفون: Neeraj Agarwal, Joseph Merriman, David D. Stenehjem, David Gill, Anitha Alex, Shiven B. Patel, Archana M. Agarwal, Andrew W. Hahn, Dan Albertson, James Arthur Kuzman
المصدر: BMC Urology
مصطلحات موضوعية: Male, 0301 basic medicine, Interleukin 2, Oncology, medicine.medical_specialty, Neutrophils, Urology, Lymphocyte, medicine.medical_treatment, Antineoplastic Agents, Cohort Studies, Leukocyte Count, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, High dose interleukin-2, Renal cell carcinoma, Internal medicine, medicine, Humans, Lymphocytes, Progression-free survival, Carcinoma, Renal Cell, Retrospective Studies, business.industry, fungi, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Kidney Neoplasms, 3. Good health, Treatment Outcome, Neutrophil lymphocyte ratio, 030104 developmental biology, medicine.anatomical_structure, Reproductive Medicine, 030220 oncology & carcinogenesis, Cohort, Immunology, Absolute neutrophil count, Interleukin-2, Biomarker (medicine), Female, business, Biomarkers, Research Article, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d12e3ea37a7f55189c04eea1563d84bTest
https://doi.org/10.1186/s12894-016-0192-0Test -
4
المؤلفون: Christine S. Falk, Bernhard Frankenberger, Dolores J. Schendel, Heike Pohla, Christiane Geiger, Elfriede Nößner
المصدر: J. Mol. Med. 87, 595-612 (2009)
مصطلحات موضوعية: Renal cell carcinoma, Adoptive cell therapy, T cell, Natural killer cell, Dendritic cell, Immunotherapy, tumor-infiltrating lymphocytes, regulatory t-cells, natural-killer-cells, minor histocompatibility antigens, high-dose interleukin-2, mature dendritic, medicine.medical_treatment, Immunotherapy, Adoptive, Models, Biological, T-Lymphocytes, Regulatory, Immune system, Drug Discovery, medicine, Animals, Antigen-presenting cell, Carcinoma, Renal Cell, Genetics (clinical), Innate immune system, business.industry, Dendritic Cells, Acquired immune system, Immunity, Innate, Kidney Neoplasms, Killer Cells, Natural, medicine.anatomical_structure, Immunology, Molecular Medicine, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3e3b8844c8664229ee2a033696171eTest
https://doi.org/10.1007/s00109-009-0455-2Test -
5
المؤلفون: Lauren C. Harshman, Benjamin I. Chung, Parth K. Modi, Francisco Gelpi-Hammerschmidt, Toni K. Choueiri, Christopher B. Allard, Eric A. Singer, Ilker Tinay, Izak Faiena, Steven L. Chang
المساهمون: Allard, Christopher B., Gelpi-Hammerschmidt, Francisco, Harshman, Lauren C., Choueiri, Toni K., Faiena, Izak, Modi, Parth, Chung, Benjamin I., Tinay, Ilker, Singer, Eric A., Chang, Steven L.
المصدر: Urologic oncology. 33(11)
مصطلحات موضوعية: Male, medicine.medical_treatment, MELANOMA, Disease, law.invention, Cohort Studies, DOUBLE-BLIND, Therapy trends, Renal cell carcinoma, law, Neoplasm Metastasis, Kidney cancer, Middle Aged, Prognosis, CANCER, Intensive care unit, STATISTICS, Kidney Neoplasms, Oncology, Tolerability, SAFETY, Cohort, SURVIVAL, Female, Immunotherapy, Hemodialysis, medicine.medical_specialty, Urology, Antineoplastic Agents, Article, Internal medicine, medicine, Humans, Carcinoma, Renal Cell, Aged, Neoplasm Staging, Toxicity, Dose-Response Relationship, Drug, business.industry, medicine.disease, High-dose interleukin-2, United States, ANTIBODY, Immunology, Interleukin-2, INTERFERON-ALPHA, business, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de577ed8edd7650b7f40d0325caf8646Test
https://pubmed.ncbi.nlm.nih.gov/26210683Test -
6
المؤلفون: Enrichetta Corgna, Maura Betti, Gemma Gatta, Fausto Roila, Pieter H.M. De Mulder
المصدر: Critical Reviews in Oncology Hematology, 64, 247-62
Critical Reviews in Oncology Hematology, 64, 3, pp. 247-62مصطلحات موضوعية: RECOMBINANT HUMAN INTERLEUKIN-2, renal cancer, CHEMOIMMUNOTHERAPY-GROUP DGCIN, STEM-CELL TRANSPLANTATION, Hematology, TUMOR-SUPPRESSOR GENE, OCCUPATIONAL RISK-FACTORS, Prognosis, survival, RANDOMIZED-TRIAL, Kidney Neoplasms, HIGH-DOSE INTERLEUKIN-2, Oncology, Interventional oncology [UMCN 1.5], Prevalence, Humans, HOGG-DUBE-SYNDROME, NEPHRON SPARING SURGERY, PHASE-II TRIAL, radical nephrectomy, Neoplasm Staging
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38fcfa405fd7c798b66fe7ce3d41fb40Test
https://pubmed.ncbi.nlm.nih.gov/17662611Test